HBAN
82
-5
MPC
39
3
GOOG
61
2
D
41
6
OKE
67
2
XRAY
25
-4
NOV
53
-2
PPL
59
2
NWL
54
-4
RF
64
-3
MU
76
-3
LH
46
-2
CINF
61
-5
PCAR
52
-4
ADBE
55
-3
CL
64
2
JBHT
62
-3
GPC
51
-2
DOW
39
-3
WY
54
-2
HBAN
82
-5
MPC
39
3
GOOG
61
2
D
41
6
OKE
67
2
XRAY
25
-4
NOV
53
-2
PPL
59
2
NWL
54
-4
RF
64
-3
MU
76
-3
LH
46
-2
CINF
61
-5
PCAR
52
-4
ADBE
55
-3
CL
64
2
JBHT
62
-3
GPC
51
-2
DOW
39
-3
WY
54
-2
Financhill
Back

JPMorgan Nasdaq Equity Premium Income ETF Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Sell
46

JEPQ
JPMorgan Nasdaq Equity Premium Income ETF

Last Price:
$59.30
Seasonality Move:
0.2%
Buy
63

GPCR
Structure Therapeutics, Inc.

Last Price:
$69.61
Seasonality Move:
-34.19%
Sell
46
JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) is a Sell

Is JPMorgan Nasdaq Equity Premium Income ETF a Buy, Sell or Hold?

  • The current JPMorgan Nasdaq Equity Premium Income ETF [JEPQ] share price is $58.89. The Score for JEPQ is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • JEPQ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

JEPQ Stock Price Chart

What is JPMorgan Nasdaq Equity Premium Income ETF's stock price today?

  • The JPMorgan Nasdaq Equity Premium Income ETF share price today is $58.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JEPQ is experiencing slight buying pressure.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $71.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

JEPQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.12 Buy
Relative Strength Index (14 RSI): 56.24 Buy
Chaikin Money Flow: 633265 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.19 - 58.91) Buy
Bollinger Bands (100): (55.81 - 58.45) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.5 Buy
Relative Strength Index (14 RSI): 72.85 Buy
Chaikin Money Flow: 1903413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.41 - 65.27) Buy
Bollinger Bands (100): (17 - 45.24) Buy

JEPQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.23 Buy
20-day SMA: 58.4 Buy
50-day SMA: 58.13 Buy
200-day SMA: 54.76 Buy
8-day EMA: 58.35 Buy
20-day EMA: 58.27 Buy
50-day EMA: 57.02 Buy
200-day EMA: 36.71 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.43 Buy
20-day SMA: 52.92 Buy
50-day SMA: 40.28 Buy
200-day SMA: 26.09 Buy
8-day EMA: 64 Buy
20-day EMA: 55.88 Buy
50-day EMA: 44.22 Buy
200-day EMA: 31.26 Buy

JPMorgan Nasdaq Equity Premium Income ETF Earnings Growth & JEPQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

JPMorgan Nasdaq Equity Premium Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):